| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| ILMN - Illumina Inc | BUY | 735 @ USD 150.28 | USD 110,456 | The ETF bought 735 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 150.28 compared to the previous average buy price of 98.6153. This is 52.4% higher than average price of previous purchases of ILMN. |
| UCB.BR - UCB SA | BUY | 344 @ EUR 302.638 | EUR 104,107 | The ETF bought 344 new shares of UCB.BR (UCB SA). The shares were bought for an average price of 302.638 compared to the previous average buy price of 224.046. This is 35.1% higher than average price of previous purchases of UCB.BR. |
| EXAS - EXACT Sciences Corporation | BUY | 993 @ USD 102.26 | USD 101,544 | The ETF bought 993 new shares of EXAS (EXACT Sciences Corporation). The shares were bought for an average price of 102.26 compared to the previous average buy price of 69.588. This is 47.0% higher than average price of previous purchases of EXAS. |
| MRNA - Moderna Inc | BUY | 2,035 @ USD 48.71 | USD 99,125 | The ETF bought 2035 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 48.71 compared to the previous average buy price of 26.2136. This is 85.8% higher than average price of previous purchases of MRNA. |
| TMO - Time Out Group plc | BUY | 156 @ USD 625.98 | USD 97,653 | The ETF bought 156 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 625.98 compared to the previous average buy price of 430.066. This is 45.6% higher than average price of previous purchases of TMO. |
| IQV - IQVIA Holdings Inc | BUY | 405 @ USD 235.31 | USD 95,301 | The ETF bought 405 new shares of IQV (IQVIA Holdings Inc). The shares were bought for an average price of 235.31 compared to the previous average buy price of 167.072. This is 40.8% higher than average price of previous purchases of IQV. |
| NTRA - Natera Inc | BUY | 392 @ USD 241.58 | USD 94,699 | The ETF bought 392 new shares of NTRA (Natera Inc). The shares were bought for an average price of 241.58 compared to the previous average buy price of 188.383. This is 28.2% higher than average price of previous purchases of NTRA. |
| GMAB.CO - | BUY | 282 @ DKK 335.341 | DKK 94,566 | The ETF bought 282 new shares of GMAB.CO (). The shares were bought for an average price of 335.341 compared to the previous average buy price of 230.938. This is 45.2% higher than average price of previous purchases of GMAB.CO. |
| JNJ - Johnson & Johnson | BUY | 413 @ USD 220.14 | USD 90,918 | The ETF bought 413 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 220.14 compared to the previous average buy price of 180.683. This is 21.8% higher than average price of previous purchases of JNJ. |
| MRK - Marks Electrical Group PLC | BUY | 795 @ USD 108.18 | USD 86,003 | The ETF bought 795 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 108.18 compared to the previous average buy price of 82.1743. This is 31.6% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 795 @ USD 108.18 | USD 86,003 | The ETF bought 795 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 108.18 compared to the previous average buy price of 82.1743. This is 31.6% higher than average price of previous purchases of MRK. |
| ROG.SW - | BUY | 189 @ CHF 441.163 | CHF 83,380 | The ETF bought 189 new shares of ROG.SW (). The shares were bought for an average price of 441.163 compared to the previous average buy price of 344.665. This is 28.0% higher than average price of previous purchases of ROG.SW. |
| BIIB - Biogen Inc | BUY | 477 @ USD 171.59 | USD 81,848 | The ETF bought 477 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 171.59 compared to the previous average buy price of 132.84. This is 29.2% higher than average price of previous purchases of BIIB. |
| GILD - Guild Esports Plc | BUY | 588 @ USD 135.93 | USD 79,927 | The ETF bought 588 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 135.93 compared to the previous average buy price of 110.34. This is 23.2% higher than average price of previous purchases of GILD. |
| NOVN.SW - | BUY | 545 @ CHF 146.556 | CHF 79,873 | The ETF bought 545 new shares of NOVN.SW (). The shares were bought for an average price of 146.556 compared to the previous average buy price of 119.879. This is 22.3% higher than average price of previous purchases of NOVN.SW. |
| 068270.KS - CELLTRION INC | BUY | 544 @ KRW 144.626 | KRW 78,677 | The ETF bought 544 new shares of 068270.KS (CELLTRION INC). The shares were bought for an average price of 144.626 compared to the previous average buy price of 123.24. This is 17.4% higher than average price of previous purchases of 068270.KS. |
| GSK.L - GlaxoSmithKline PLC | BUY | 3,176 @ GBP 24.4288 | GBP 77,586 | The ETF bought 3176 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 24.4288 compared to the previous average buy price of 20.2382. This is 20.7% higher than average price of previous purchases of GSK.L. |
| AMGN - Amgen Inc | BUY | 220 @ USD 344.75 | USD 75,845 | The ETF bought 220 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 344.75 compared to the previous average buy price of 302.081. This is 14.1% higher than average price of previous purchases of AMGN. |
| DHR - Danaher Corporation | BUY | 319 @ USD 235.01 | USD 74,968 | The ETF bought 319 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 235.01 compared to the previous average buy price of 202.333. This is 16.2% higher than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 319 @ USD 235.01 | USD 74,968 | The ETF bought 319 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 235.01 compared to the previous average buy price of 202.333. This is 16.2% higher than average price of previous purchases of DHR. |
| GH - Guardant Health Inc | BUY | 652 @ USD 114.75 | USD 74,817 | The ETF bought 652 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 114.75 compared to the previous average buy price of 65.6603. This is 74.8% higher than average price of previous purchases of GH. |
| ABBV - AbbVie Inc | BUY | 341 @ USD 219.26 | USD 74,768 | The ETF bought 341 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 219.26 compared to the previous average buy price of 207.606. This is 5.6% higher than average price of previous purchases of ABBV. |
| HOLX - Hologic Inc | BUY | 994 @ USD 75.05 | USD 74,600 | The ETF bought 994 new shares of HOLX (Hologic Inc). The shares were bought for an average price of 75.05 compared to the previous average buy price of 67.1446. This is 11.8% higher than average price of previous purchases of HOLX. |
| MDT - Medtronic PLC | BUY | 736 @ USD 100.88 | USD 74,248 | The ETF bought 736 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 100.88 compared to the previous average buy price of 91.9154. This is 9.8% higher than average price of previous purchases of MDT. |
| MEDP - Medpace Holdings Inc | BUY | 126 @ USD 588.05 | USD 74,094 | The ETF bought 126 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 588.05 compared to the previous average buy price of 419.854. This is 40.1% higher than average price of previous purchases of MEDP. |
| A - Agilent Technologies Inc | BUY | 537 @ USD 135.05 | USD 72,522 | The ETF bought 537 new shares of A (Agilent Technologies Inc). The shares were bought for an average price of 135.05 compared to the previous average buy price of 124.348. This is 8.6% higher than average price of previous purchases of A. |
| RVTY - Revvity Inc. | BUY | 620 @ USD 116.73 | USD 72,373 | The ETF bought 620 new shares of RVTY (Revvity Inc.). The shares were bought for an average price of 116.73 compared to the previous average buy price of 100.935. This is 15.6% higher than average price of previous purchases of RVTY. |
| EW - Edwards Lifesciences Corp | BUY | 854 @ USD 83.66 | USD 71,446 | The ETF bought 854 new shares of EW (Edwards Lifesciences Corp). The shares were bought for an average price of 83.66 compared to the previous average buy price of 75.573. This is 10.7% higher than average price of previous purchases of EW. |
| BMY - Bloomsbury Publishing Plc | BUY | 1,296 @ USD 54.65 | USD 70,826 | The ETF bought 1296 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 54.65 compared to the previous average buy price of 53.6591. This is 1.8% higher than average price of previous purchases of BMY. |
| NBIX - Neurocrine Biosciences Inc | BUY | 519 @ USD 136.18 | USD 70,677 | The ETF bought 519 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 136.18 compared to the previous average buy price of 129.198. This is 5.4% higher than average price of previous purchases of NBIX. |
| PFE - Pfizer Inc | BUY | 2,665 @ USD 25.65 | USD 68,357 | The ETF bought 2665 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 25.65 compared to the previous average buy price of 24.43. This is 5.0% higher than average price of previous purchases of PFE. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | BUY | 55 @ KRW 1229.32 | KRW 67,613 | The ETF bought 55 new shares of 207940.KS (SAMSUNG BIOLOGICS LTD). The shares were bought for an average price of 1229.32 compared to the previous average buy price of 836.507. This is 47.0% higher than average price of previous purchases of 207940.KS. |
| LONN.SW - | BUY | 92 @ CHF 703.884 | CHF 64,757 | The ETF bought 92 new shares of LONN.SW (). The shares were bought for an average price of 703.884 compared to the previous average buy price of 649.464. This is 8.4% higher than average price of previous purchases of LONN.SW. |
| ISRG - Intuitive Surgical Inc | BUY | 122 @ USD 523.99 | USD 63,927 | The ETF bought 122 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 523.99 compared to the previous average buy price of 542.527. This is -3.4% lower than average price of previous purchases of ISRG. |
| EXEL - Exelixis Inc | BUY | 1,436 @ USD 44.27 | USD 63,572 | The ETF bought 1436 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 44.27 compared to the previous average buy price of 39.6352. This is 11.7% higher than average price of previous purchases of EXEL. |
| BSX - Boston Scientific Corporation | BUY | 652 @ USD 92.51 | USD 60,317 | The ETF bought 652 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 92.51 compared to the previous average buy price of 97.223. This is -4.8% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 652 @ USD 92.51 | USD 60,317 | The ETF bought 652 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 92.51 compared to the previous average buy price of 97.223. This is -4.8% lower than average price of previous purchases of BSX. |
| PODD - Insulet Corporation | BUY | 217 @ USD 271.6 | USD 58,937 | The ETF bought 217 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 271.6 compared to the previous average buy price of 284.2. This is -4.4% lower than average price of previous purchases of PODD. |
| CRL - Creightons Plc | BUY | 258 @ USD 219.61 | USD 56,659 | The ETF bought 258 new shares of CRL (Creightons Plc). The shares were bought for an average price of 219.61 compared to the previous average buy price of 175.539. This is 25.1% higher than average price of previous purchases of CRL. |
| TECH - Bio-Techne Corp | BUY | 825 @ USD 68.16 | USD 56,232 | The ETF bought 825 new shares of TECH (Bio-Techne Corp). The shares were bought for an average price of 68.16 compared to the previous average buy price of 60.0423. This is 13.5% higher than average price of previous purchases of TECH. |
| DXCM - DexCom Inc | BUY | 763 @ USD 72.86 | USD 55,592 | The ETF bought 763 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 72.86 compared to the previous average buy price of 78.1726. This is -6.8% lower than average price of previous purchases of DXCM. |
| ABT - Abbott Laboratories | BUY | 482 @ USD 107.42 | USD 51,776 | The ETF bought 482 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 107.42 compared to the previous average buy price of 124.721. This is -13.9% lower than average price of previous purchases of ABT. |
| HALO - Halozyme Therapeutics Inc | BUY | 649 @ USD 69.22 | USD 44,924 | The ETF bought 649 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 69.22 compared to the previous average buy price of 62.8825. This is 10.1% higher than average price of previous purchases of HALO. |
| RGEN - Repligen Corporation | BUY | 276 @ USD 162.33 | USD 44,803 | The ETF bought 276 new shares of RGEN (Repligen Corporation). The shares were bought for an average price of 162.33 compared to the previous average buy price of 150.345. This is 8.0% higher than average price of previous purchases of RGEN. |
| 4523.T - Eisai Co., Ltd. | BUY | 1,500 @ JPY 28.9599 | JPY 43,440 | The ETF bought 1500 new shares of 4523.T (Eisai Co., Ltd.). The shares were bought for an average price of 28.9599 compared to the previous average buy price of 28.6593. This is 1.0% higher than average price of previous purchases of 4523.T. |
| 7701.T - Shimadzu Corporation | BUY | 1,500 @ JPY 27.948 | JPY 41,922 | The ETF bought 1500 new shares of 7701.T (Shimadzu Corporation). The shares were bought for an average price of 27.948 compared to the previous average buy price of 26.5586. This is 5.2% higher than average price of previous purchases of 7701.T. |
| SRT3.DE - Sartorius AG | BUY | 133 @ EUR 304.284 | EUR 40,470 | The ETF bought 133 new shares of SRT3.DE (Sartorius AG). The shares were bought for an average price of 304.284 compared to the previous average buy price of 258.982. This is 17.5% higher than average price of previous purchases of SRT3.DE. |
| AXSM - Axsome Therapeutics Inc | BUY | 202 @ USD 185.96 | USD 37,564 | The ETF bought 202 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 185.96 compared to the previous average buy price of 129.863. This is 43.2% higher than average price of previous purchases of AXSM. |
| PME.AX - | BUY | 296 @ AUD 124.337 | AUD 36,804 | The ETF bought 296 new shares of PME.AX (). The shares were bought for an average price of 124.337 compared to the previous average buy price of 161.114. This is -22.8% lower than average price of previous purchases of PME.AX. |
| PRAX - Praxis Precision Medicines Inc | BUY | 108 @ USD 311.71 | USD 33,665 | The ETF bought 108 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 311.71 compared to the previous average buy price of 224.561. This is 38.8% higher than average price of previous purchases of PRAX. |
| BIO - Bio-Rad Laboratories Inc | BUY | 111 @ USD 296.57 | USD 32,919 | The ETF bought 111 new shares of BIO (Bio-Rad Laboratories Inc). The shares were bought for an average price of 296.57 compared to the previous average buy price of 294.445. This is 0.7% higher than average price of previous purchases of BIO. |
| BIO - Biotest Aktiengesellschaft | BUY | 111 @ USD 296.57 | USD 32,919 | The ETF bought 111 new shares of BIO (Biotest Aktiengesellschaft). The shares were bought for an average price of 296.57 compared to the previous average buy price of 294.445. This is 0.7% higher than average price of previous purchases of BIO. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 306 @ USD 102.87 | USD 31,478 | The ETF bought 306 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 102.87 compared to the previous average buy price of 74.309. This is 38.4% higher than average price of previous purchases of RYTM. |
| PTCT - PTC Therapeutics Inc | BUY | 418 @ USD 75.25 | USD 31,455 | The ETF bought 418 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 75.25 compared to the previous average buy price of 60.8668. This is 23.6% higher than average price of previous purchases of PTCT. |
| BIM.PA - BioMerieux | BUY | 257 @ EUR 121.925 | EUR 31,335 | The ETF bought 257 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 121.925 compared to the previous average buy price of 123.429. This is -1.2% lower than average price of previous purchases of BIM.PA. |
| IPN.PA - Ipsen SA | BUY | 191 @ EUR 160.607 | EUR 30,676 | The ETF bought 191 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 160.607 compared to the previous average buy price of 126.679. This is 26.8% higher than average price of previous purchases of IPN.PA. |
| ALKS - Alkermes Plc | BUY | 874 @ USD 33.61 | USD 29,375 | The ETF bought 874 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 33.61 compared to the previous average buy price of 30.1815. This is 11.4% higher than average price of previous purchases of ALKS. |
| MMS - LYXETFETUSITETFP | BUY | 297 @ USD 98.59 | USD 29,281 | The ETF bought 297 new shares of MMS (LYXETFETUSITETFP). The shares were bought for an average price of 98.59 compared to the previous average buy price of 78.7811. This is 25.1% higher than average price of previous purchases of MMS. |
| 6869.T - Sysmex Corporation | BUY | 2,700 @ JPY 9.8947 | JPY 26,716 | The ETF bought 2700 new shares of 6869.T (Sysmex Corporation). The shares were bought for an average price of 9.8947 compared to the previous average buy price of 14.106. This is -29.9% lower than average price of previous purchases of 6869.T. |
| 298380.KQ - ABL Bio Inc. | BUY | 189 @ KRW 135.075 | KRW 25,529 | The ETF bought 189 new shares of 298380.KQ (ABL Bio Inc.). The shares were bought for an average price of 135.075 compared to the previous average buy price of 107.093. This is 26.1% higher than average price of previous purchases of 298380.KQ. |
| LNTH - Lantheus Holdings Inc | BUY | 362 @ USD 67.51 | USD 24,439 | The ETF bought 362 new shares of LNTH (Lantheus Holdings Inc). The shares were bought for an average price of 67.51 compared to the previous average buy price of 75.5372. This is -10.6% lower than average price of previous purchases of LNTH. |
| TGTX - TG Therapeutics Inc | BUY | 762 @ USD 31.2 | USD 23,774 | The ETF bought 762 new shares of TGTX (TG Therapeutics Inc). The shares were bought for an average price of 31.2 compared to the previous average buy price of 32.8643. This is -5.1% lower than average price of previous purchases of TGTX. |
| 7747.T - Asahi Intecc Co., Ltd. | BUY | 1,300 @ JPY 17.7086 | JPY 23,021 | The ETF bought 1300 new shares of 7747.T (Asahi Intecc Co., Ltd.). The shares were bought for an average price of 17.7086 compared to the previous average buy price of 17.255. This is 2.6% higher than average price of previous purchases of 7747.T. |
| SFZN.SW - | BUY | 208 @ CHF 110.259 | CHF 22,934 | The ETF bought 208 new shares of SFZN.SW (). The shares were bought for an average price of 110.259 compared to the previous average buy price of 123.167. This is -10.5% lower than average price of previous purchases of SFZN.SW. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 101 @ USD 201.15 | USD 20,316 | The ETF bought 101 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 201.15 compared to the previous average buy price of 132.521. This is 51.8% higher than average price of previous purchases of LGND. |
| SECT-B.ST - | BUY | 769 @ SEK 24.762 | SEK 19,042 | The ETF bought 769 new shares of SECT-B.ST (). The shares were bought for an average price of 24.762 compared to the previous average buy price of 27.6891. This is -10.6% lower than average price of previous purchases of SECT-B.ST. |
| LIVN - LivaNova PLC | BUY | 288 @ USD 63.16 | USD 18,190 | The ETF bought 288 new shares of LIVN (LivaNova PLC). The shares were bought for an average price of 63.16 compared to the previous average buy price of 52.7244. This is 19.8% higher than average price of previous purchases of LIVN. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 652 @ USD 26.84 | USD 17,500 | The ETF bought 652 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 26.84 compared to the previous average buy price of 21.0852. This is 27.3% higher than average price of previous purchases of ACAD. |
| CGON - CG Oncology, Inc. Common stock | BUY | 324 @ USD 53.81 | USD 17,434 | The ETF bought 324 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 53.81 compared to the previous average buy price of 42.6164. This is 26.3% higher than average price of previous purchases of CGON. |
| BEAM - Beam Therapeutics Inc | BUY | 533 @ USD 31.56 | USD 16,821 | The ETF bought 533 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 31.56 compared to the previous average buy price of 19.1284. This is 65.0% higher than average price of previous purchases of BEAM. |
| VCYT - Veracyte Inc | BUY | 385 @ USD 42.27 | USD 16,274 | The ETF bought 385 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 42.27 compared to the previous average buy price of 36.3115. This is 16.4% higher than average price of previous purchases of VCYT. |
| IDYA - Ideaya Biosciences Inc | BUY | 462 @ USD 34.8 | USD 16,078 | The ETF bought 462 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 34.8 compared to the previous average buy price of 24.6619. This is 41.1% higher than average price of previous purchases of IDYA. |
| CPRX - Catalyst Pharmaceuticals Inc | BUY | 645 @ USD 23.58 | USD 15,209 | The ETF bought 645 new shares of CPRX (Catalyst Pharmaceuticals Inc). The shares were bought for an average price of 23.58 compared to the previous average buy price of 22.507. This is 4.8% higher than average price of previous purchases of CPRX. |
| ACLX - Arcellx Inc | BUY | 220 @ USD 67.7 | USD 14,894 | The ETF bought 220 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 67.7 compared to the previous average buy price of 64.9645. This is 4.2% higher than average price of previous purchases of ACLX. |
| BANB.SW - | BUY | 168 @ CHF 88.5875 | CHF 14,883 | The ETF bought 168 new shares of BANB.SW (). The shares were bought for an average price of 88.5875 compared to the previous average buy price of 69.6076. This is 27.3% higher than average price of previous purchases of BANB.SW. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 796 @ USD 18.55 | USD 14,766 | The ETF bought 796 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 18.55 compared to the previous average buy price of 7.46501. This is 148.5% higher than average price of previous purchases of ADPT. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 298 @ USD 48.25 | USD 14,379 | The ETF bought 298 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 48.25 compared to the previous average buy price of 40.3831. This is 19.5% higher than average price of previous purchases of SUPN. |
| VRDN - Viridian Therapeutics Inc | BUY | 436 @ USD 32.93 | USD 14,357 | The ETF bought 436 new shares of VRDN (Viridian Therapeutics Inc). The shares were bought for an average price of 32.93 compared to the previous average buy price of 30.4282. This is 8.2% higher than average price of previous purchases of VRDN. |
| TXG - 10X Genomics Inc | BUY | 596 @ USD 22.38 | USD 13,338 | The ETF bought 596 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 22.38 compared to the previous average buy price of 13.9734. This is 60.2% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 596 @ USD 22.38 | USD 13,338 | The ETF bought 596 new shares of TXG (Terex Corporation). The shares were bought for an average price of 22.38 compared to the previous average buy price of 13.9734. This is 60.2% higher than average price of previous purchases of TXG. |
| EKTA-B.ST - | BUY | 1,951 @ SEK 6.81787 | SEK 13,302 | The ETF bought 1951 new shares of EKTA-B.ST (). The shares were bought for an average price of 6.81787 compared to the previous average buy price of 5.77545. This is 18.0% higher than average price of previous purchases of EKTA-B.ST. |
| BAVA.CO - | BUY | 413 @ DKK 31.2748 | DKK 12,916 | The ETF bought 413 new shares of BAVA.CO (). The shares were bought for an average price of 31.2748 compared to the previous average buy price of 26.1216. This is 19.7% higher than average price of previous purchases of BAVA.CO. |
| TWST - Twist Bioscience Corp | BUY | 295 @ USD 42.94 | USD 12,667 | The ETF bought 295 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 42.94 compared to the previous average buy price of 36.3124. This is 18.3% higher than average price of previous purchases of TWST. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | BUY | 147 @ KRW 82.1366 | KRW 12,074 | The ETF bought 147 new shares of 326030.KS (SK BIOPHARMACEUTICALS LTD). The shares were bought for an average price of 82.1366 compared to the previous average buy price of 79.105. This is 3.8% higher than average price of previous purchases of 326030.KS. |
| DIA.MI - DiaSorin SpA | BUY | 140 @ EUR 86.159 | EUR 12,062 | The ETF bought 140 new shares of DIA.MI (DiaSorin SpA). The shares were bought for an average price of 86.159 compared to the previous average buy price of 63.455. This is 35.8% higher than average price of previous purchases of DIA.MI. |
| TECN.SW - | BUY | 67 @ CHF 176.161 | CHF 11,803 | The ETF bought 67 new shares of TECN.SW (). The shares were bought for an average price of 176.161 compared to the previous average buy price of 192.248. This is -8.4% lower than average price of previous purchases of TECN.SW. |
| 6951.T - JEOL Ltd. | BUY | 300 @ JPY 39.0855 | JPY 11,726 | The ETF bought 300 new shares of 6951.T (JEOL Ltd.). The shares were bought for an average price of 39.0855 compared to the previous average buy price of 33.1911. This is 17.8% higher than average price of previous purchases of 6951.T. |
| 9995.HK - REMEGEN LTD H | BUY | 1,000 @ HKD 11.5662 | HKD 11,566 | The ETF bought 1000 new shares of 9995.HK (REMEGEN LTD H). The shares were bought for an average price of 11.5662 compared to the previous average buy price of 10.0398. This is 15.2% higher than average price of previous purchases of 9995.HK. |
| SRPT - Sarepta Therapeutics Inc | BUY | 525 @ USD 21.13 | USD 11,093 | The ETF bought 525 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 21.13 compared to the previous average buy price of 42.4769. This is -50.3% lower than average price of previous purchases of SRPT. |
| NEOG - Neogen Corporation | BUY | 1,126 @ USD 9.8 | USD 11,035 | The ETF bought 1126 new shares of NEOG (Neogen Corporation). The shares were bought for an average price of 9.8 compared to the previous average buy price of 9.64998. This is 1.6% higher than average price of previous purchases of NEOG. |
| CRVL - CorVel Corp | BUY | 155 @ USD 69.88 | USD 10,831 | The ETF bought 155 new shares of CRVL (CorVel Corp). The shares were bought for an average price of 69.88 compared to the previous average buy price of 110.637. This is -36.8% lower than average price of previous purchases of CRVL. |
| HLUN-B.CO - | BUY | 1,470 @ DKK 7.17283 | DKK 10,544 | The ETF bought 1470 new shares of HLUN-B.CO (). The shares were bought for an average price of 7.17283 compared to the previous average buy price of 6.31095. This is 13.7% higher than average price of previous purchases of HLUN-B.CO. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 2,154 @ USD 4.73 | USD 10,188 | The ETF bought 2154 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 4.73 compared to the previous average buy price of 5.07249. This is -6.8% lower than average price of previous purchases of RXRX. |
| QDEL - Quidel Corporation | BUY | 362 @ USD 28.09 | USD 10,169 | The ETF bought 362 new shares of QDEL (Quidel Corporation). The shares were bought for an average price of 28.09 compared to the previous average buy price of 29.577. This is -5.0% lower than average price of previous purchases of QDEL. |
| ATRC - AtriCure Inc | BUY | 259 @ USD 39.07 | USD 10,119 | The ETF bought 259 new shares of ATRC (AtriCure Inc). The shares were bought for an average price of 39.07 compared to the previous average buy price of 34.4108. This is 13.5% higher than average price of previous purchases of ATRC. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 695 @ USD 14.53 | USD 10,098 | The ETF bought 695 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 14.53 compared to the previous average buy price of 12.5784. This is 15.5% higher than average price of previous purchases of AUPH. |
| DVAX - Dynavax Technologies Corporation | BUY | 644 @ USD 15.51 | USD 9,988 | The ETF bought 644 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 15.51 compared to the previous average buy price of 13.7616. This is 12.7% higher than average price of previous purchases of DVAX. |
| CHEMM.CO - | BUY | 92 @ DKK 107.687 | DKK 9,907 | The ETF bought 92 new shares of CHEMM.CO (). The shares were bought for an average price of 107.687 compared to the previous average buy price of 82.0523. This is 31.2% higher than average price of previous purchases of CHEMM.CO. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 228 @ USD 42.2 | USD 9,622 | The ETF bought 228 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 42.2 compared to the previous average buy price of 40.6611. This is 3.8% higher than average price of previous purchases of KNSA. |
| 13.HK - HUTCHMED (CHINA) LTD | BUY | 3,000 @ HKD 3.11851 | HKD 9,356 | The ETF bought 3000 new shares of 13.HK (HUTCHMED (CHINA) LTD). The shares were bought for an average price of 3.11851 compared to the previous average buy price of 2.99535. This is 4.1% higher than average price of previous purchases of 13.HK. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | BUY | 6,000 @ HKD 1.50925 | HKD 9,056 | The ETF bought 6000 new shares of 3933.HK (THE UNITED LABORATORIES INTERNATIO). The shares were bought for an average price of 1.50925 compared to the previous average buy price of 1.64666. This is -8.3% lower than average price of previous purchases of 3933.HK. |
| RCUS - Arcus Biosciences Inc | BUY | 401 @ USD 22.13 | USD 8,874 | The ETF bought 401 new shares of RCUS (Arcus Biosciences Inc). The shares were bought for an average price of 22.13 compared to the previous average buy price of 10.6061. This is 108.7% higher than average price of previous purchases of RCUS. |
| HRMY - Harmony Biosciences Holdings | BUY | 240 @ USD 36.82 | USD 8,837 | The ETF bought 240 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 36.82 compared to the previous average buy price of 33.8447. This is 8.8% higher than average price of previous purchases of HRMY. |
| STOK - Stoke Therapeutics Inc | BUY | 294 @ USD 29.46 | USD 8,661 | The ETF bought 294 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 29.46 compared to the previous average buy price of 13.9015. This is 111.9% higher than average price of previous purchases of STOK. |
| NEU.AX - | BUY | 686 @ AUD 12.13 | AUD 8,321 | The ETF bought 686 new shares of NEU.AX (). The shares were bought for an average price of 12.13 compared to the previous average buy price of 9.24901. This is 31.1% higher than average price of previous purchases of NEU.AX. |
| FTRE - Fortrea Holdings Inc. | BUY | 486 @ USD 16.83 | USD 8,179 | The ETF bought 486 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 16.83 compared to the previous average buy price of 11.5601. This is 45.6% higher than average price of previous purchases of FTRE. |
| IBRX - Immunitybio Inc | BUY | 1,206 @ USD 6.45 | USD 7,779 | The ETF bought 1206 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 6.45 compared to the previous average buy price of 2.84145. This is 127.0% higher than average price of previous purchases of IBRX. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 1,132 @ USD 6.79 | USD 7,686 | The ETF bought 1132 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 6.79 compared to the previous average buy price of 7.72121. This is -12.1% lower than average price of previous purchases of BCRX. |
| 4887.T - Sawai Group Holdings Co., Ltd. | BUY | 500 @ JPY 15.3369 | JPY 7,668 | The ETF bought 500 new shares of 4887.T (Sawai Group Holdings Co., Ltd.). The shares were bought for an average price of 15.3369 compared to the previous average buy price of 13.7134. This is 11.8% higher than average price of previous purchases of 4887.T. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | BUY | 2,000 @ HKD 3.8212 | HKD 7,642 | The ETF bought 2000 new shares of 2252.HK (SHANGHAI MICROPORT MEDBOT CLASS H). The shares were bought for an average price of 3.8212 compared to the previous average buy price of 3.18365. This is 20.0% higher than average price of previous purchases of 2252.HK. |
| AXGN - Axogen Inc | BUY | 231 @ USD 32.83 | USD 7,584 | The ETF bought 231 new shares of AXGN (Axogen Inc). The shares were bought for an average price of 32.83 compared to the previous average buy price of 19.8345. This is 65.5% higher than average price of previous purchases of AXGN. |
| NVCR - Novocure Ltd | BUY | 553 @ USD 13.45 | USD 7,438 | The ETF bought 553 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 13.45 compared to the previous average buy price of 16.0281. This is -16.1% lower than average price of previous purchases of NVCR. |
| BIOA-B.ST - | BUY | 215 @ SEK 34.5335 | SEK 7,425 | The ETF bought 215 new shares of BIOA-B.ST (). The shares were bought for an average price of 34.5335 compared to the previous average buy price of 30.7011. This is 12.5% higher than average price of previous purchases of BIOA-B.ST. |
| NUVB - Nuvation Bio Inc | BUY | 1,319 @ USD 5.59 | USD 7,373 | The ETF bought 1319 new shares of NUVB (Nuvation Bio Inc). The shares were bought for an average price of 5.59 compared to the previous average buy price of 7.96072. This is -29.8% lower than average price of previous purchases of NUVB. |
| 2162.HK - KEYMED BIOSCIENCES INC | BUY | 1,000 @ HKD 7.30259 | HKD 7,303 | The ETF bought 1000 new shares of 2162.HK (KEYMED BIOSCIENCES INC). The shares were bought for an average price of 7.30259 compared to the previous average buy price of 5.486. This is 33.1% higher than average price of previous purchases of 2162.HK. |
| NVAX - Novavax Inc | BUY | 794 @ USD 9.17 | USD 7,281 | The ETF bought 794 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 9.17 compared to the previous average buy price of 6.58053. This is 39.4% higher than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 794 @ USD 9.17 | USD 7,281 | The ETF bought 794 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 9.17 compared to the previous average buy price of 6.58053. This is 39.4% higher than average price of previous purchases of NVAX. |
| PHARM.AS - Pharming Group NV | BUY | 3,672 @ EUR 1.96703 | EUR 7,223 | The ETF bought 3672 new shares of PHARM.AS (Pharming Group NV). The shares were bought for an average price of 1.96703 compared to the previous average buy price of 0.986964. This is 99.3% higher than average price of previous purchases of PHARM.AS. |
| TNDM - Tandem Diabetes Care Inc | BUY | 361 @ USD 19.9 | USD 7,184 | The ETF bought 361 new shares of TNDM (Tandem Diabetes Care Inc). The shares were bought for an average price of 19.9 compared to the previous average buy price of 21.2477. This is -6.3% lower than average price of previous purchases of TNDM. |
| ONT.L - Oxford Nanopore Technologies Ltd | BUY | 3,021 @ GBP 2.31944 | GBP 7,007 | The ETF bought 3021 new shares of ONT.L (Oxford Nanopore Technologies Ltd). The shares were bought for an average price of 2.31944 compared to the previous average buy price of 1.77809. This is 30.4% higher than average price of previous purchases of ONT.L. |
| PHM.MC - Pharma Mar SA | BUY | 71 @ EUR 96.7642 | EUR 6,870 | The ETF bought 71 new shares of PHM.MC (Pharma Mar SA). The shares were bought for an average price of 96.7642 compared to the previous average buy price of 87.8973. This is 10.1% higher than average price of previous purchases of PHM.MC. |
| GLPG.AS - Galapagos NV | BUY | 199 @ EUR 34.473 | EUR 6,860 | The ETF bought 199 new shares of GLPG.AS (Galapagos NV). The shares were bought for an average price of 34.473 compared to the previous average buy price of 30.2292. This is 14.0% higher than average price of previous purchases of GLPG.AS. |
| 237690.KQ - ST Pharm Co.,Ltd. | BUY | 69 @ KRW 95.2349 | KRW 6,571 | The ETF bought 69 new shares of 237690.KQ (ST Pharm Co.,Ltd.). The shares were bought for an average price of 95.2349 compared to the previous average buy price of 61.7016. This is 54.3% higher than average price of previous purchases of 237690.KQ. |
| CSTL - Castle Biosciences Inc | BUY | 152 @ USD 42.24 | USD 6,420 | The ETF bought 152 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 42.24 compared to the previous average buy price of 23.3483. This is 80.9% higher than average price of previous purchases of CSTL. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 269 @ USD 23.24 | USD 6,252 | The ETF bought 269 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 23.24 compared to the previous average buy price of 19.7628. This is 17.6% higher than average price of previous purchases of ZYME. |
| CERT - Certara Inc | BUY | 616 @ USD 10 | USD 6,160 | The ETF bought 616 new shares of CERT (Certara Inc). The shares were bought for an average price of 10 compared to the previous average buy price of 10.2846. This is -2.8% lower than average price of previous purchases of CERT. |
| DYVOX.ST - | BUY | 573 @ SEK 10.7265 | SEK 6,146 | The ETF bought 573 new shares of DYVOX.ST (). The shares were bought for an average price of 10.7265 compared to the previous average buy price of 7.59363. This is 41.3% higher than average price of previous purchases of DYVOX.ST. |
| BLFS - BioLife Solutions Inc | BUY | 247 @ USD 24.87 | USD 6,143 | The ETF bought 247 new shares of BLFS (BioLife Solutions Inc). The shares were bought for an average price of 24.87 compared to the previous average buy price of 25.3925. This is -2.1% lower than average price of previous purchases of BLFS. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 389 @ USD 15.76 | USD 6,131 | The ETF bought 389 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 15.76 compared to the previous average buy price of 13.3181. This is 18.3% higher than average price of previous purchases of AMLX. |
| RLAY - Relay Therapeutics Inc | BUY | 787 @ USD 7.43 | USD 5,847 | The ETF bought 787 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 7.43 compared to the previous average buy price of 7.14381. This is 4.0% higher than average price of previous purchases of RLAY. |
| ASTH - Astrana Health Inc | BUY | 213 @ USD 27.16 | USD 5,785 | The ETF bought 213 new shares of ASTH (Astrana Health Inc). The shares were bought for an average price of 27.16 compared to the previous average buy price of 26.612. This is 2.1% higher than average price of previous purchases of ASTH. |
| EVT.DE - Evotec SE | BUY | 793 @ EUR 7.24262 | EUR 5,743 | The ETF bought 793 new shares of EVT.DE (Evotec SE). The shares were bought for an average price of 7.24262 compared to the previous average buy price of 6.63643. This is 9.1% higher than average price of previous purchases of EVT.DE. |
| CDNA - Caredx Inc | BUY | 272 @ USD 20.42 | USD 5,554 | The ETF bought 272 new shares of CDNA (Caredx Inc). The shares were bought for an average price of 20.42 compared to the previous average buy price of 19.2204. This is 6.2% higher than average price of previous purchases of CDNA. |
| 4587.T - PeptiDream Inc. | BUY | 500 @ JPY 10.7612 | JPY 5,381 | The ETF bought 500 new shares of 4587.T (PeptiDream Inc.). The shares were bought for an average price of 10.7612 compared to the previous average buy price of 11.0017. This is -2.2% lower than average price of previous purchases of 4587.T. |
| ANAB - AnaptysBio Inc | BUY | 113 @ USD 47.54 | USD 5,372 | The ETF bought 113 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 47.54 compared to the previous average buy price of 25.2031. This is 88.6% higher than average price of previous purchases of ANAB. |
| SDGR - Schrodinger Inc | BUY | 326 @ USD 16.42 | USD 5,353 | The ETF bought 326 new shares of SDGR (Schrodinger Inc). The shares were bought for an average price of 16.42 compared to the previous average buy price of 20.3053. This is -19.1% lower than average price of previous purchases of SDGR. |
| 039200.KQ - Oscotec Inc. | BUY | 176 @ KRW 29.9826 | KRW 5,277 | The ETF bought 176 new shares of 039200.KQ (Oscotec Inc.). The shares were bought for an average price of 29.9826 compared to the previous average buy price of 21.5965. This is 38.8% higher than average price of previous purchases of 039200.KQ. |
| ABCL - Abcellera Biologics Inc | BUY | 1,217 @ USD 4.24 | USD 5,160 | The ETF bought 1217 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 4.24 compared to the previous average buy price of 3.65767. This is 15.9% higher than average price of previous purchases of ABCL. |
| 302440.KS - SK BIOSCIENCE LTD | BUY | 138 @ KRW 35.1332 | KRW 4,848 | The ETF bought 138 new shares of 302440.KS (SK BIOSCIENCE LTD). The shares were bought for an average price of 35.1332 compared to the previous average buy price of 35.8034. This is -1.9% lower than average price of previous purchases of 302440.KS. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 404 @ USD 11.95 | USD 4,828 | The ETF bought 404 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 11.95 compared to the previous average buy price of 9.22742. This is 29.5% higher than average price of previous purchases of DAWN. |
| ARVN - Arvinas Inc | BUY | 373 @ USD 12.89 | USD 4,808 | The ETF bought 373 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 12.89 compared to the previous average buy price of 11.4279. This is 12.8% higher than average price of previous purchases of ARVN. |
| IART - Integra LifeSciences Holdings | BUY | 385 @ USD 11.9 | USD 4,582 | The ETF bought 385 new shares of IART (Integra LifeSciences Holdings). The shares were bought for an average price of 11.9 compared to the previous average buy price of 15.6296. This is -23.9% lower than average price of previous purchases of IART. |
| JANX - Janux Therapeutics Inc | BUY | 305 @ USD 14.81 | USD 4,517 | The ETF bought 305 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 14.81 compared to the previous average buy price of 24.2934. This is -39.0% lower than average price of previous purchases of JANX. |
| EUZ.DE - Eckert & Ziegler SE | BUY | 229 @ EUR 18.3064 | EUR 4,192 | The ETF bought 229 new shares of EUZ.DE (Eckert & Ziegler SE). The shares were bought for an average price of 18.3064 compared to the previous average buy price of 18.5489. This is -1.3% lower than average price of previous purchases of EUZ.DE. |
| PACB - Pacific Biosciences of California | BUY | 1,603 @ USD 2.58 | USD 4,136 | The ETF bought 1603 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 2.58 compared to the previous average buy price of 1.43923. This is 79.3% higher than average price of previous purchases of PACB. |
| VIR - Vir Biotechnology Inc | BUY | 541 @ USD 7.56 | USD 4,090 | The ETF bought 541 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 7.56 compared to the previous average buy price of 6.92842. This is 9.1% higher than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 541 @ USD 7.56 | USD 4,090 | The ETF bought 541 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 7.56 compared to the previous average buy price of 6.92842. This is 9.1% higher than average price of previous purchases of VIR. |
| 007390.KQ - NatureCell Co.,Ltd. | BUY | 280 @ KRW 14.292 | KRW 4,002 | The ETF bought 280 new shares of 007390.KQ (NatureCell Co.,Ltd.). The shares were bought for an average price of 14.292 compared to the previous average buy price of 21.1933. This is -32.6% lower than average price of previous purchases of 007390.KQ. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 1,477 @ USD 2.64 | USD 3,899 | The ETF bought 1477 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.64 compared to the previous average buy price of 2.42836. This is 8.7% higher than average price of previous purchases of IOVA. |
| 328130.KQ - Lunit Inc. | BUY | 142 @ KRW 26.8104 | KRW 3,807 | The ETF bought 142 new shares of 328130.KQ (Lunit Inc.). The shares were bought for an average price of 26.8104 compared to the previous average buy price of 35.5945. This is -24.7% lower than average price of previous purchases of 328130.KQ. |
| CTKB - Cytek Biosciences Inc | BUY | 698 @ USD 5.27 | USD 3,678 | The ETF bought 698 new shares of CTKB (Cytek Biosciences Inc). The shares were bought for an average price of 5.27 compared to the previous average buy price of 5.66555. This is -7.0% lower than average price of previous purchases of CTKB. |
| RO.SW - | BUY | 8 @ CHF 451.683 | CHF 3,613 | The ETF bought 8 new shares of RO.SW (). The shares were bought for an average price of 451.683 compared to the previous average buy price of 376.621. This is 19.9% higher than average price of previous purchases of RO.SW. |
| KURA - Kura Oncology Inc | BUY | 417 @ USD 8.63 | USD 3,599 | The ETF bought 417 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 8.63 compared to the previous average buy price of 10.2026. This is -15.4% lower than average price of previous purchases of KURA. |
| VLA.PA - Valneva SE | BUY | 728 @ EUR 4.82763 | EUR 3,515 | The ETF bought 728 new shares of VLA.PA (Valneva SE). The shares were bought for an average price of 4.82763 compared to the previous average buy price of 2.99779. This is 61.0% higher than average price of previous purchases of VLA.PA. |
| EMBC - Embecta Corp | BUY | 306 @ USD 10.94 | USD 3,348 | The ETF bought 306 new shares of EMBC (Embecta Corp). The shares were bought for an average price of 10.94 compared to the previous average buy price of 12.6757. This is -13.7% lower than average price of previous purchases of EMBC. |
| XVIVO.ST - | BUY | 131 @ SEK 24.984 | SEK 3,273 | The ETF bought 131 new shares of XVIVO.ST (). The shares were bought for an average price of 24.984 compared to the previous average buy price of 37.8682. This is -34.0% lower than average price of previous purchases of XVIVO.ST. |
| 096530.KQ - Seegene, Inc. | BUY | 193 @ KRW 16.9526 | KRW 3,272 | The ETF bought 193 new shares of 096530.KQ (Seegene, Inc.). The shares were bought for an average price of 16.9526 compared to the previous average buy price of 17.3135. This is -2.1% lower than average price of previous purchases of 096530.KQ. |
| RGNX - Regenxbio Inc | BUY | 236 @ USD 13.79 | USD 3,254 | The ETF bought 236 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 13.79 compared to the previous average buy price of 9.19579. This is 50.0% higher than average price of previous purchases of RGNX. |
| 7575.T - Japan Lifeline Co., Ltd. | BUY | 300 @ JPY 10.0686 | JPY 3,021 | The ETF bought 300 new shares of 7575.T (Japan Lifeline Co., Ltd.). The shares were bought for an average price of 10.0686 compared to the previous average buy price of 10.167. This is -1.0% lower than average price of previous purchases of 7575.T. |
| LAB - Standard Biotools Inc | BUY | 1,854 @ USD 1.55 | USD 2,874 | The ETF bought 1854 new shares of LAB (Standard Biotools Inc). The shares were bought for an average price of 1.55 compared to the previous average buy price of 1.36334. This is 13.7% higher than average price of previous purchases of LAB. |
| MYGN - Myriad Genetics Inc | BUY | 488 @ USD 5.87 | USD 2,865 | The ETF bought 488 new shares of MYGN (Myriad Genetics Inc). The shares were bought for an average price of 5.87 compared to the previous average buy price of 8.31841. This is -29.4% lower than average price of previous purchases of MYGN. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 701 @ USD 3.71 | USD 2,601 | The ETF bought 701 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.71 compared to the previous average buy price of 3.029. This is 22.5% higher than average price of previous purchases of MRVI. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 303 @ USD 8.01 | USD 2,427 | The ETF bought 303 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 8.01 compared to the previous average buy price of 5.63531. This is 42.1% higher than average price of previous purchases of VNDA. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | BUY | 800 @ HKD 2.91591 | HKD 2,333 | The ETF bought 800 new shares of 1877.HK (SHANGHAI JUNSHI BIOSCIENCES LTD H). The shares were bought for an average price of 2.91591 compared to the previous average buy price of 2.66077. This is 9.6% higher than average price of previous purchases of 1877.HK. |
| EVH - Evolent Health Inc | BUY | 574 @ USD 3.94 | USD 2,262 | The ETF bought 574 new shares of EVH (Evolent Health Inc). The shares were bought for an average price of 3.94 compared to the previous average buy price of 8.62868. This is -54.3% lower than average price of previous purchases of EVH. |
| SLP - Sylvania Platinum Limited | BUY | 82 @ USD 20.84 | USD 1,709 | The ETF bought 82 new shares of SLP (Sylvania Platinum Limited). The shares were bought for an average price of 20.84 compared to the previous average buy price of 25.5767. This is -18.5% lower than average price of previous purchases of SLP. |
| 4549.T - Eiken Chemical Co., Ltd. | BUY | 100 @ JPY 15.8872 | JPY 1,589 | The ETF bought 100 new shares of 4549.T (Eiken Chemical Co., Ltd.). The shares were bought for an average price of 15.8872 compared to the previous average buy price of 13.8065. This is 15.1% higher than average price of previous purchases of 4549.T. |
| 4974.T - Takara Bio Inc. | BUY | 200 @ JPY 5.27464 | JPY 1,055 | The ETF bought 200 new shares of 4974.T (Takara Bio Inc.). The shares were bought for an average price of 5.27464 compared to the previous average buy price of 5.6196. This is -6.1% lower than average price of previous purchases of 4974.T. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 124 @ USD 7.53 | USD 934 | The ETF bought 124 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 7.53 compared to the previous average buy price of 11.0783. This is -32.0% lower than average price of previous purchases of ARCT. |
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2026-01-23 this would crystalise an overall loss. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.92742 | KRW 0 | |